Hot Investor Mandate 5: Impact Investment Fund Seeking Healthtech Companies with Low Regulatory Hurdles

4 Jan

An impact investment fund based in San Francisco, California is investing from a $400 million fund, and makes investments in several sectors including cleantech, IT and healthcare. As the firm invests in a variety of sectors and stages, allocations vary considerably but initial investments are typically between $5-15 million. The firm primarily invests in the USA but also has the ability to invest worldwide. The firm typically leads investment rounds but is also open to co-investing as part of a strong syndicate. The firm plans to invest in a total of 25-30 companies from the current fund.

In healthcare, the firm is interested in healthcare IT, medical device and diagnostic startups that have an approved product or a product that does not require FDA approval. The firm also wants to see evidence that the company’s approach has efficacy in achieving a health benefit or impact. While the firm will consider any indication area, the firm has a preference for investing in chronic diseases, including diabetes and prediabetes, and also behavioral conditions.

The firm does not invest in companies that still face regulatory risks for their products. The firm also places a strong emphasis on reimbursement and/or the product having established a revenue generating model.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: